Sean Salmon - Aug 3, 2023 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & President Cardiovascular
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Aug 3, 2023
Transactions value $
-$369,137
Form type
4
Date filed
8/7/2023, 08:20 PM
Previous filing
Aug 2, 2023
Next filing
Dec 12, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +5.6K +12.05% $0.00 52.1K Aug 3, 2023 Direct F1, F2
transaction MDT Ordinary Shares Tax liability -$369K -4.37K -8.39% $84.49 47.7K Aug 3, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Options Exercise -5.6K -100% 0 Aug 3, 2023 Performance Share Unit 5.6K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents.
F2 Includes 201 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1.
F3 Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023.
F4 Each performance share unit represented a contingent right to receive one share of Medtronic common stock.
F5 The performance share units vested on August 3, 2023.